Patents Assigned to Tyrogenex, Inc.
  • Kinase inhibitor compounds
    Patent number: 8524709
    Abstract: The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of kinase-mediated processes, and treatment of disease and disease symptoms, particularly those mediated by certain kinase enzymes.
    Type: Grant
    Filed: January 12, 2012
    Date of Patent: September 3, 2013
    Assignee: Tyrogenex, Inc.
    Inventors: Congxin Liang, Ming Qi, Shu Gao, Zhigang Li
  • KINASE INHIBITOR COMPOUNDS
    Publication number: 20120115866
    Abstract: The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of kinase-mediated processes, and treatment of disease and disease symptoms, particularly those mediated by certain kinase enzymes.
    Type: Application
    Filed: January 12, 2012
    Publication date: May 10, 2012
    Applicant: TYROGENEX, INC.
    Inventors: Congxin Liang, Ming Qi, Shu Gao, Zhigang Li
  • Kinase inhibitor compounds
    Patent number: 8039470
    Abstract: The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of kinase-mediated processes, and treatment of disease and disease symptoms, particularly those mediated by certain kinase enzymes.
    Type: Grant
    Filed: January 28, 2010
    Date of Patent: October 18, 2011
    Assignee: Tyrogenex, Inc.
    Inventors: Congxin Liang, Ming Qi, Shu Gao, Zhigang Li
  • KINASE INHIBITOR COMPOUNDS
    Publication number: 20110224212
    Abstract: The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of kinase-mediated processes, and treatment of disease and disease symptoms, particularly those mediated by certain kinase enzymes.
    Type: Application
    Filed: May 16, 2011
    Publication date: September 15, 2011
    Applicant: TYROGENEX, INC.
    Inventors: Congxin Liang, Ming Qi, Shu Gao, Zhigang Li
  • Kinase inhibitor compounds
    Patent number: 7683057
    Abstract: The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of kinase-mediated processes, and treatment of disease and disease symptoms, particularly those mediated by certain kinase enzymes.
    Type: Grant
    Filed: December 28, 2007
    Date of Patent: March 23, 2010
    Assignee: Tyrogenex, Inc.
    Inventors: Congxin Liang, Ming Qi, Shu Gao, Zhigang Li